The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(p-methyl)-benzyl-4-(1H-(1-methyl)-imidazole-4-sulfonyloxy)-2-benzoxazolone ID: ALA4781766
PubChem CID: 162664425
Max Phase: Preclinical
Molecular Formula: C19H17N3O5S
Molecular Weight: 399.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(Cn2c(=O)oc3cccc(OS(=O)(=O)c4cn(C)cn4)c32)cc1
Standard InChI: InChI=1S/C19H17N3O5S/c1-13-6-8-14(9-7-13)10-22-18-15(26-19(22)23)4-3-5-16(18)27-28(24,25)17-11-21(2)12-20-17/h3-9,11-12H,10H2,1-2H3
Standard InChI Key: NKJRVFNMPYQGBB-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
24.8005 -15.6876 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.3960 -14.9818 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
23.9871 -15.6850 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.3988 -12.5302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3976 -13.3498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1057 -13.7587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1039 -12.1214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8125 -12.5266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8127 -13.3498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5957 -13.6040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.0794 -12.9378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5953 -12.2721 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.1059 -14.5759 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.6905 -14.5763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8966 -12.9375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.5876 -14.4205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2912 -14.8361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6000 -13.7632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8036 -13.5956 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.3981 -14.3012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9439 -14.9048 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.4698 -12.8497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2784 -15.6514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9812 -16.0669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6939 -15.6654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6994 -14.8440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9960 -14.4321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3981 -16.0800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 8 1 0
6 13 1 0
13 2 1 0
2 14 1 0
11 15 2 0
10 16 1 0
16 17 1 0
14 18 2 0
18 19 1 0
19 20 1 0
20 21 2 0
21 14 1 0
19 22 1 0
17 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 17 1 0
25 28 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 399.43Molecular Weight (Monoisotopic): 399.0889AlogP: 2.45#Rotatable Bonds: 5Polar Surface Area: 96.33Molecular Species: NEUTRALHBA: 8HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.19CX LogP: 3.35CX LogD: 3.35Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.48Np Likeness Score: -1.10
References 1. Tang L,Gao XH,Zhao B,Luo JR,Shi XY,Ge R,Ban SR,Li QS. (2020) Design and synthesis of new disubstituted benzoxazolone derivatives that act as iNOS inhibitors with potent anti-inflammatory activity against LPS-induced acute lung injury (ALI)., 28 (21.0): [PMID:33065432 ] [10.1016/j.bmc.2020.115733 ]